These emerging therapies , Tirzepatide , represent a significant advancement in treating metabolic dysfunction and conceivably related ailments . These drugs are categorized as GLP-1 pathway https://umarweyk756688.glifeblog.com/39993626/semaglutide-a-comprehensive-dive-into-incretin-agents